Published in Lab Business Week, July 16th, 2006
Study 1: Insulin secretion appears to determine diabetes control in type 2 diabetic patients treated with metformin alone or with combined metformin and glyburide.
"Defects in insulin secretion and sensitivity, two major determinants of glycemic control, can occur and progress or not in parallel. The present study was designed to compare the respective roles of both determinants on HbA1c, in type 2 diabetic patients, according to whether or not residual beta-cell function was stimulated with insulin secretagogues," scientists writing in the European...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-07-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.